Study to Evaluate Satisfaction of DuoResp® SPIROMAX® in Asthma and COPD Treatment

- Patient Satisfaction
- Completed

Study Title: Study to Evaluate Satisfaction and Usability of DuoRespֲ® SPIROMAXֲ® in Asthma and COPD Treatment

Teva Identifier: BFS-AS-40074 | DRKS00006542

ClinicalTrials.gov Identifier: NCT02384577

Study Status: Completed

Trial Condition(s): Patient Satisfaction

Interventions: Drug: Budesonide, Formoterol Fumarate Dihydrate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 07/01/2014 - 09/01/2016

Study Type

Observational